Stories > Atara Biotherapeutics at Health Care Conference

Atara Biotherapeutics at Health Care Conference

Advancements in Cancer Treatment and Mar...

Allogene Therapeutics Restates Financial...

Autolus Thrives with $350M Offering and ...

AB-2100 Phase 1/2 Trial Initiated

AI-Powered Antigen Research Partnership

Affini-T Therapeutics at J.P. Morgan Hea...